OpenLB
Open Library of Bioscience
Advanced Search
Cell stem cell
01 06, 2022;29 (1): 131-148.e10.

Multilayer omics analysis reveals a non-classical retinoic acid signaling axis that regulates hematopoietic stem cell identity.

Katharina Schönberger, Nadine Obier, Mari Carmen Romero-Mulero, Pierre Cauchy, Julian Mess, Polina V Pavlovich, Yu Wei Zhang, Michael Mitterer, Jasmin Rettkowski, Maria-Eleni Lalioti, Karin Jäcklein, Jonathan D Curtis, Betty Féret, Pia Sommerkamp, Claudia Morganti, Keisuke Ito, Norbert B Ghyselinck, Eirini Trompouki, Joerg M Buescher, Erika L Pearce, Nina Cabezas-Wallscheid
Author Information
  1. Katharina Schönberger: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; International Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB), Freiburg, Germany.
  2. Nadine Obier: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  3. Mari Carmen Romero-Mulero: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  4. Pierre Cauchy: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  5. Julian Mess: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; Spemann Graduate School of Biology and Medicine (SGBM), Freiburg, Germany; Centre for Integrative Biological Signalling Studies (CIBSS), Freiburg, Germany.
  6. Polina V Pavlovich: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; International Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB), Freiburg, Germany.
  7. Yu Wei Zhang: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; International Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB), Freiburg, Germany.
  8. Michael Mitterer: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  9. Jasmin Rettkowski: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany; Spemann Graduate School of Biology and Medicine (SGBM), Freiburg, Germany.
  10. Maria-Eleni Lalioti: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  11. Karin Jäcklein: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  12. Jonathan D Curtis: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  13. Betty Féret: Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), UMR 7104 Centre National de la Recherche Scientifique (CNRS) et Université de Strasbourg (UNISTRA), U1258 Institut National de la Santé et de la Recherche Médicale (INSERM), Illkirch, France.
  14. Pia Sommerkamp: German Cancer Research Center (DKFZ), Heidelberg, Germany.
  15. Claudia Morganti: Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Departments of Cell Biology and Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.
  16. Keisuke Ito: Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Departments of Cell Biology and Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.
  17. Norbert B Ghyselinck: Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), UMR 7104 Centre National de la Recherche Scientifique (CNRS) et Université de Strasbourg (UNISTRA), U1258 Institut National de la Santé et de la Recherche Médicale (INSERM), Illkirch, France.
  18. Eirini Trompouki: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  19. Joerg M Buescher: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany.
  20. Erika L Pearce: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; The Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Johns Hopkins University, Baltimore, MD, USA.
  21. Nina Cabezas-Wallscheid: Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany; Centre for Integrative Biological Signalling Studies (CIBSS), Freiburg, Germany. Electronic address: cabezas@ie-freiburg.mpg.de.
PMID: 34706256 DOI: 10.1016/j.stem.2021.10.002

Abstract

Hematopoietic stem cells (HSCs) rely on complex regulatory networks to preserve stemness. Due to the scarcity of HSCs, technical challenges have limited our insights into the interplay between metabolites, transcription, and the epigenome. In this study, we generated low-input metabolomics, transcriptomics, chromatin accessibility, and chromatin immunoprecipitation data, revealing distinct metabolic hubs that are enriched in HSCs and their downstream multipotent progenitors. Mechanistically, we uncover a non-classical retinoic acid (RA) signaling axis that regulates HSC function. We show that HSCs rely on Cyp26b1, an enzyme conventionally considered to limit RA effects in the cell. In contrast to the traditional view, we demonstrate that Cyp26b1 is indispensable for production of the active metabolite 4-oxo-RA. Further, RA receptor beta (Rarb) is required for complete transmission of 4-oxo-RA-mediated signaling to maintain stem cells. Our findings emphasize that a single metabolite controls stem cell fate by instructing epigenetic and transcriptional attributes.

Keywords

4-oxo-RA Cyp26b1 Rarb at-RA epigenetics hematopoietic stem cells metabolites self-renewal vitamin A

References

  1. Teratology. 1989 Apr;39(4):341-8 [PMID: 2749577]
  2. Leukemia. 2020 Nov;34(11):3077-3081 [PMID: 32152463]
  3. Nucleic Acids Res. 2014 Jul;42(Web Server issue):W187-91 [PMID: 24799436]
  4. Nat Methods. 2017 Oct;14(10):959-962 [PMID: 28846090]
  5. Redox Biol. 2018 Jul;17:171-179 [PMID: 29702404]
  6. Nutrients. 2017 Feb 20;9(2): [PMID: 28230720]
  7. Nat Cell Biol. 2016 Aug;18(8):823-32 [PMID: 27428307]
  8. Blood. 1991 Nov 15;78(10):2696-701 [PMID: 1668609]
  9. Curr Opin Genet Dev. 1998 Feb;8(1):28-35 [PMID: 9529602]
  10. F1000Res. 2015 Oct 14;4:1070 [PMID: 26674615]
  11. Cell Stem Cell. 2016 Aug 4;19(2):192-204 [PMID: 27345838]
  12. Adv Drug Deliv Rev. 2010 Oct 30;62(13):1285-98 [PMID: 20654663]
  13. Nucleic Acids Res. 2016 May 5;44(8):3567-85 [PMID: 26673693]
  14. Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R139-47 [PMID: 15809266]
  15. Bioinformatics. 2014 Apr 1;30(7):923-30 [PMID: 24227677]
  16. J Biol Chem. 2014 Aug 1;289(31):21663-72 [PMID: 24928506]
  17. Cancer Cell. 2016 Jan 11;29(1):104-116 [PMID: 26766592]
  18. Nat Commun. 2020 Jan 2;11(1):63 [PMID: 31896743]
  19. Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5 [PMID: 27079975]
  20. Bioinformatics. 2019 Nov 1;35(22):4757-4759 [PMID: 31134269]
  21. Genes Dev. 2001 Jan 15;15(2):213-25 [PMID: 11157777]
  22. Nature. 2017 Sep 28;549(7673):476-481 [PMID: 28825709]
  23. Ital J Biochem. 1975 Nov-Dec;24(6):325-34 [PMID: 767289]
  24. Dev Dyn. 1994 Dec;201(4):334-43 [PMID: 7894072]
  25. Dev Cell. 2004 Mar;6(3):411-22 [PMID: 15030763]
  26. J Invest Dermatol. 2005 Jul;125(1):143-53 [PMID: 15982314]
  27. Cell. 2017 May 18;169(5):807-823.e19 [PMID: 28479188]
  28. Nat Protoc. 2009;4(1):44-57 [PMID: 19131956]
  29. Endocrinology. 2007 Oct;148(10):4560-7 [PMID: 17584971]
  30. Nucleic Acids Res. 2015 Jul 1;43(W1):W57-64 [PMID: 25925574]
  31. Cell Stem Cell. 2020 May 7;26(5):722-738.e7 [PMID: 32229311]
  32. Cell. 2008 Dec 12;135(6):1118-29 [PMID: 19062086]
  33. Nucl Recept Signal. 2012;10:e003 [PMID: 22438793]
  34. Oncogene. 2005 Apr 18;24(17):2810-26 [PMID: 15838517]
  35. Genome Biol. 2014;15(12):550 [PMID: 25516281]
  36. Genesis. 2002 Feb;32(2):91-4 [PMID: 11857787]
  37. Apoptosis. 2017 Jul;22(7):920-932 [PMID: 28409399]
  38. Nature. 2011 Jan 20;469(7330):343-9 [PMID: 21248841]
  39. Sci Signal. 2016 Mar 15;9(419):rs1 [PMID: 26980443]
  40. Science. 2006 Apr 28;312(5773):596-600 [PMID: 16574820]
  41. Blood. 2018 Apr 12;131(15):1639-1653 [PMID: 29463564]
  42. J Exp Med. 2006 May 15;203(5):1283-93 [PMID: 16682494]
  43. J Biol Chem. 1999 Sep 17;274(38):26783-8 [PMID: 10480883]
  44. Cancer Treat Res. 2010;145:219-35 [PMID: 20306254]
  45. Antioxid Redox Signal. 2014 Oct 10;21(11):1605-19 [PMID: 24762207]
  46. Cell Stem Cell. 2018 May 3;22(5):740-754.e7 [PMID: 29727682]
  47. Exp Biol Med (Maywood). 2006 May;231(5):619-31 [PMID: 16636311]
  48. Blood. 2010 Jan 14;115(2):247-56 [PMID: 19887676]
  49. Cell Rep. 2013 Dec 26;5(6):1704-13 [PMID: 24332856]
  50. Cell. 2008 Feb 22;132(4):631-44 [PMID: 18295580]
  51. J Biol Chem. 2002 Aug 30;277(35):31491-8 [PMID: 12070176]
  52. Methods. 2021 Mar;187:44-53 [PMID: 32240773]
  53. Nature. 1993 Nov 25;366(6453):340-4 [PMID: 8247127]
  54. Cell Stem Cell. 2014 Oct 2;15(4):507-522 [PMID: 25158935]
  55. J Proteome Res. 2019 May 3;18(5):2065-2077 [PMID: 30827117]
  56. Nat Commun. 2021 Jan 27;12(1):608 [PMID: 33504783]
  57. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1502-6 [PMID: 1371359]
  58. Front Pharmacol. 2020 Jul 09;11:1044 [PMID: 32742264]
  59. Nat Rev Mol Cell Biol. 2014 Apr;15(4):243-56 [PMID: 24651542]
  60. Life Sci Alliance. 2019 Jul 22;2(4): [PMID: 31331983]
  61. Blood. 2000 Jan 15;95(2):470-7 [PMID: 10627451]
  62. Immunity. 2009 Jan 16;30(1):155-67 [PMID: 19144320]
  63. Blood. 1999 Jul 15;94(2):483-95 [PMID: 10397716]
  64. Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13919-24 [PMID: 11698662]
  65. Curr Top Med Chem. 2013;13(12):1402-28 [PMID: 23688132]
  66. Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):17841-17847 [PMID: 31431533]
  67. Science. 1995 Sep 8;269(5229):1427-9 [PMID: 7660125]
  68. Radiat Res. 1961 Feb;14:213-22 [PMID: 13776896]
  69. Nucleic Acids Res. 2020 Jan 8;48(D1):D498-D503 [PMID: 31691815]
  70. Prev Med. 1989 Sep;18(5):624-45 [PMID: 2694159]
  71. Cell Stem Cell. 2010 Sep 3;7(3):380-90 [PMID: 20804973]
  72. Development. 2007 Jan;134(1):177-87 [PMID: 17164423]
  73. Blood. 2007 Dec 15;110(13):4188-97 [PMID: 17823307]
  74. Biochim Biophys Acta. 2012 Jan;1821(1):21-56 [PMID: 22020178]
  75. Nature. 2014 May 1;509(7498):49-54 [PMID: 24670665]
  76. Annu Rev Pathol. 2011;6:345-64 [PMID: 21073338]
  77. Nat Commun. 2020 Aug 26;11(1):4265 [PMID: 32848154]
  78. Cell Stem Cell. 2015 Jun 4;16(6):712-24 [PMID: 26004780]
  79. Int J Mol Sci. 2019 Jun 14;20(12): [PMID: 31207999]
  80. Cell Stem Cell. 2020 Mar 5;26(3):420-430.e6 [PMID: 32059807]
  81. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 [PMID: 16199517]
  82. Development. 2019 Jul 4;146(13): [PMID: 31273085]
  83. Front Cell Dev Biol. 2020 Feb 28;8:115 [PMID: 32185173]
  84. Genome Biol. 2008;9(9):R137 [PMID: 18798982]
  85. Nat Genet. 2002 May;31(1):84-8 [PMID: 11953746]
  86. Nat Methods. 2012 Mar 04;9(4):357-9 [PMID: 22388286]
  87. Int J Hematol. 2015 Apr;101(4):319-29 [PMID: 25749719]
  88. Nat Commun. 2016 Oct 12;7:13125 [PMID: 27731316]
  89. Cell Metab. 2020 Oct 6;32(4):629-642.e8 [PMID: 32905798]
  90. Blood. 2018 May 24;131(21):e1-e11 [PMID: 29588278]
  91. FASEB J. 2020 Dec;34(12):15788-15804 [PMID: 33105029]
  92. Cell Stem Cell. 2019 Mar 7;24(3):405-418.e7 [PMID: 30849366]
  93. Bioinformatics. 2013 Jan 1;29(1):15-21 [PMID: 23104886]
  94. Cell. 2017 Sep 7;170(6):1079-1095.e20 [PMID: 28823558]
  95. Cell Rep. 2015 Nov 17;13(7):1505-1518 [PMID: 26549448]
  96. Endocrinology. 1996 Feb;137(2):479-85 [PMID: 8593792]
  97. Cell Stem Cell. 2013 Jan 3;12(1):49-61 [PMID: 23290136]
  98. Genetics. 2019 Oct;213(2):651-663 [PMID: 31492806]
  99. Int J Hematol. 2019 Jan;109(1):18-27 [PMID: 30219988]
  100. Seikagaku. 2014 Dec;86(6):755-65 [PMID: 25675813]
  101. Elife. 2021 Jan 20;10: [PMID: 33470192]
  102. Sci Rep. 2017 Nov 30;7(1):16684 [PMID: 29192143]
  103. Nat Commun. 2019 Jan 31;10(1):523 [PMID: 30705272]
  104. Epigenetics Chromatin. 2016 Nov 1;9:48 [PMID: 27822313]
  105. Development. 1992 Mar;114(3):805-13 [PMID: 1319895]
  106. Int J Dev Biol. 1995 Aug;39(4):587-96 [PMID: 8619957]
  107. Exp Cell Res. 1999 Aug 1;250(2):284-97 [PMID: 10413584]
  108. Cell Stem Cell. 2012 Sep 7;11(3):429-39 [PMID: 22958934]
  109. Blood. 2005 Apr 1;105(7):2724-32 [PMID: 15598809]
  110. Nucleic Acids Res. 2013 Nov;41(21):e201 [PMID: 24071585]
  111. Asian-Australas J Anim Sci. 2018 Jun;31(6):791-797 [PMID: 29381903]
  112. Front Genet. 2019 Aug 28;10:764 [PMID: 31555321]
  113. Cell Stem Cell. 2020 Mar 5;26(3):359-376.e7 [PMID: 32109377]
  114. J Biol Chem. 1997 Jul 18;272(29):17921-8 [PMID: 9218416]
  115. Bioinformatics. 2010 Mar 15;26(6):841-2 [PMID: 20110278]
  116. Nucleic Acids Res. 2012 Aug;40(15):e114 [PMID: 22718975]
  117. J Nutr Biochem. 2018 Dec;62:230-246 [PMID: 30317068]
  118. Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16121-6 [PMID: 24043786]
  119. Cell Stem Cell. 2017 Dec 7;21(6):725-729.e4 [PMID: 29198942]
  120. Cell Stem Cell. 2011 Oct 4;9(4):298-310 [PMID: 21982230]
  121. Blood. 1992 Dec 15;80(12):3044-50 [PMID: 1281687]

Grants

  1. R01 DK098263/NIDDK NIH HHS
  2. R01 DK115577/NIDDK NIH HHS
  3. R01 HL148852/NHLBI NIH HHS

MeSH Term

Cell Differentiation
Hematopoietic Stem Cells
Retinoic Acid 4-Hydroxylase
Signal Transduction
Tretinoin

Chemicals

Tretinoin
Retinoic Acid 4-Hydroxylase
Journal Article Research Support, Non-U.S. Gov't

Word Cloud

Similar Articles

Cited By